Impressions of our mini-symposium on Cancer Radiotheranostics
Take a look at some impressions of our recent mini-symposium on radiotheranostics! A big thank you to all the incredible speakers who shared their expertise and insights on this transformative field. During this symposium Karuna Adhikari successfully defended her PhD dissertation!
Improved FAP-radiotheranostics for personalized cancer treatment
Improved FAP-radiotheranostics for personalized cancer treatment Cancer-associated fibroblasts (CAFs) are a group of tumor stromal cells typically associated with cancer growth and metastasis. These CAFs show high expression of the fibroblast activation protein (FAP) on the cell membrane. Due to the selective FAP expression and cancer-specific distribution, CAFs have emerged as a promising cancer diagnostic marker and an attractive therapeutic target.
European Molecular Imaging Meeting (EMIM) 2023 Award
Louis Lauwerys a PhD student from CREANT has won a poster award at the European Molecular Imaging Meeting (EMIM) in Salzburg (Austria) for his work on the design and evaluation of a novel caspase-3 radiotracer for monitoring apoptosis in response to cancer therapy. Congratulations Louis!